Ocular Regenerative Society 20/20 and Beyond
My Session Status
When:
10:45 AM, Saturday 27 Jun 2020
(1 hour 30 minutes)
Where:
Vancouver Convention Centre (East Building)
- Ballroom A
Theme:
Ocular Regenerative Medicine
LEARNING OBJECTIVES
At the end of this session, participants will be able to:
At the end of this session, participants will be able to:
- Describe the latest evidence for KPRO vs Limbal Stem Cell Transplantation therapy for patients suffering with limbal stem cell disease (LSCD)
- Describe how corneal endothelial cells in Fuchs endothelial corneal dystrophy display increased cellular migration compared to normal controls.
- Outline a reasonable course of medical treatment for patients with LSCD from contact lens wear
- Outline the benefits of diagnostic testing for LSCD and describe if it is necessary
- Describe the long-term benefits and risks of SLET for recurrent pterygium
- Describe how corneal endothelial cells in Fuchs endothelial corneal dystrophy undergo endothelial-to-mesechymal transition likely resulting in the pro-migratory phenotype.
CANMEDS ROLES: Medical Expert, Professional, Scholar, Health Advocate
Sub Sessions
10:45 AM -
10:53 AM |
8 minutes
11:10 AM -
11:25 AM |
15 minutes
11:25 AM -
11:37 AM |
12 minutes
11:40 AM -
11:48 AM |
8 minutes
11:50 AM -
11:58 AM |
8 minutes
12:00 PM -
12:15 PM |
15 minutes